Advertisement

Topics

Gene Therapy in U.S. Is On Track for Approval as Early as Next Year

16:35 EDT 18 Oct 2016 | MIT Technology Review

Spark Therapeutics is within striking distance of a landmark green light from the FDA for its treatment for certain forms of blindness.

Original Article: Gene Therapy in U.S. Is On Track for Approval as Early as Next Year

NEXT ARTICLE

More From BioPortfolio on "Gene Therapy in U.S. Is On Track for Approval as Early as Next Year"

Quick Search
Advertisement